DEFA14A: Apellis Pharmaceuticals Sets Date for 2025 Annual Stockholders Meeting

Apellis Pharmaceuticals announces its annual meeting of stockholders to be held virtually on June 3, 2025, covering director elections, auditor ratification, and executive compensation votes.

Summary

• Apellis Pharmaceuticals will hold its Annual Meeting of Stockholders on Tuesday, June 3, 2025, at 9:30 AM Eastern Time.
• The meeting will be held live via the internet at www.proxydocs.com/APLS.
• Stockholders of record as of April 7, 2025, are eligible to vote.
• The agenda includes the election of three Class II directors with terms expiring at the 2028 Annual Meeting.
• Stockholders will also vote to ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• An advisory vote will be held to approve the compensation paid to named executive officers.
• Additionally, stockholders will vote on the frequency of future advisory votes on executive compensation (every 1 year, 2 years, or 3 years).

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, indicating a neutral but necessary process for corporate governance. The sentiment is moderately positive as it reflects the company's adherence to regulatory requirements and shareholder engagement.

Positives

• The meeting is being held virtually, providing accessibility for stockholders.
• Stockholders have multiple options for voting (online, phone, mail).
• The agenda includes standard corporate governance matters such as director elections and auditor ratification.

Future Outlook

The proxy statement outlines the matters to be voted on at the upcoming annual meeting, which are standard corporate governance procedures.

Industry Context

This announcement is a routine part of corporate governance, ensuring that shareholders have the opportunity to participate in key decisions regarding the company's direction and oversight.

Stakeholder Impact

• Shareholders have the opportunity to influence the company's direction through voting.
• The outcome of the votes will impact the composition of the Board of Directors and the selection of the independent auditor.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• Stockholders can attend the virtual Annual Meeting on June 3, 2025.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Statement, Apellis Pharmaceuticals, Voting, Directors, Executive Compensation, Auditor